Mélanie Guyot

602 total citations
14 papers, 332 citations indexed

About

Mélanie Guyot is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mélanie Guyot has authored 14 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mélanie Guyot's work include Angiogenesis and VEGF in Cancer (5 papers), Vagus Nerve Stimulation Research (4 papers) and Renal cell carcinoma treatment (3 papers). Mélanie Guyot is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Vagus Nerve Stimulation Research (4 papers) and Renal cell carcinoma treatment (3 papers). Mélanie Guyot collaborates with scholars based in France, Monaco and United States. Mélanie Guyot's co-authors include Gilles Pagès, Damien Ambrosetti, Renaud Grépin, Sandy Giuliano, Caroline Hilmi, Hélène Simonnet, Philippe Blancou, Jean‐Yves Scoazec, Thomas Simon and Arun Sridhar and has published in prestigious journals such as Nature Biotechnology, Cancer Research and British Journal of Pharmacology.

In The Last Decade

Mélanie Guyot

13 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mélanie Guyot France 11 151 82 81 51 51 14 332
Kinga Blecharz Germany 10 173 1.1× 199 2.4× 57 0.7× 61 1.2× 41 0.8× 11 506
Breanna Wallace United States 6 217 1.4× 86 1.0× 124 1.5× 39 0.8× 28 0.5× 11 406
Ming Huang China 14 276 1.8× 162 2.0× 57 0.7× 50 1.0× 76 1.5× 24 555
Fernando Neria Spain 11 192 1.3× 31 0.4× 55 0.7× 22 0.4× 38 0.7× 32 369
Lingwei Kong China 10 119 0.8× 32 0.4× 86 1.1× 35 0.7× 54 1.1× 42 352
Marine Poittevin France 10 132 0.9× 179 2.2× 45 0.6× 32 0.6× 119 2.3× 11 472
Olivia Singh Canada 9 174 1.2× 33 0.4× 41 0.5× 62 1.2× 51 1.0× 13 372
Lianhua Zhao China 11 156 1.0× 89 1.1× 68 0.8× 59 1.2× 45 0.9× 23 444

Countries citing papers authored by Mélanie Guyot

Since Specialization
Citations

This map shows the geographic impact of Mélanie Guyot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Guyot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Guyot more than expected).

Fields of papers citing papers by Mélanie Guyot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Guyot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Guyot. The network helps show where Mélanie Guyot may publish in the future.

Co-authorship network of co-authors of Mélanie Guyot

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Guyot. A scholar is included among the top collaborators of Mélanie Guyot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Guyot. Mélanie Guyot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Péraldi‐Roux, Sylvie, Sahla Belhadj, Mélanie Guyot, et al.. (2024). The flavonoid resokaempferol improves insulin secretion from healthy and dysfunctional pancreatic β‐cells. British Journal of Pharmacology. 182(1). 52–68.
2.
Simon, Thomas, Mélanie Guyot, Kourosh Saeb‐Parsy, et al.. (2023). The cholinergic anti-inflammatory pathway inhibits inflammation without lymphocyte relay. Frontiers in Neuroscience. 17. 1125492–1125492. 21 indexed citations
3.
Guyot, Mélanie, Thomas Simon, Douglas Daoudlarian, et al.. (2023). Environmental signals perceived by the brain abate pro-metastatic monocytes by dampening glucocorticoids receptor signaling. Cancer Cell International. 23(1). 15–15. 1 indexed citations
4.
Guyot, Mélanie, Thomas Simon, Franck Ceppo, et al.. (2019). Pancreatic nerve electrostimulation inhibits recent-onset autoimmune diabetes. Nature Biotechnology. 37(12). 1446–1451. 40 indexed citations
5.
Guyot, Mélanie, Thomas Simon, Franck Ceppo, et al.. (2019). Apical splenic nerve electrical stimulation discloses an anti-inflammatory pathway relying on adrenergic and nicotinic receptors in myeloid cells. Brain Behavior and Immunity. 80. 238–246. 49 indexed citations
6.
Grépin, Renaud, Mélanie Guyot, Jérôme Durivault, et al.. (2019). The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor. Theranostics. 10(3). 1107–1121. 14 indexed citations
7.
8.
Guyot, Mélanie, Caroline Hilmi, Damien Ambrosetti, et al.. (2016). Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies. Oncotarget. 8(6). 9174–9188. 19 indexed citations
9.
Guyot, Mélanie & Gilles Pagès. (2015). VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing. Methods in molecular biology. 1332. 3–23. 28 indexed citations
10.
Giuliano, Sandy, Mélanie Guyot, Renaud Grépin, & Gilles Pagès. (2014). The ELR+CXCL chemokines and their receptors CXCR1/CXCR2. OncoImmunology. 3(4). e28399–e28399. 11 indexed citations
11.
Grépin, Renaud, Mélanie Guyot, Sandy Giuliano, et al.. (2013). The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma. Cancer Research. 74(3). 873–883. 80 indexed citations
12.
Meiler, Jens, et al.. (2012). Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancer. Journal of Cancer Research and Clinical Oncology. 138(8). 1385–1394. 2 indexed citations
13.
Hilmi, Caroline, Mélanie Guyot, & Gilles Pagès. (2011). VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy. Journal of Nucleic Acids. 2012. 1–7. 27 indexed citations
14.
Ortholan, Cécile, Jérôme Durivault, Jean‐Michel Hannoun‐Lévi, et al.. (2010). Bevacizumab/docetaxel association is more efficient than docetaxel alone in reducing breast and prostate cancer cell growth: A new paradigm for understanding the therapeutic effect of combined treatment. European Journal of Cancer. 46(16). 3022–3036. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kinga Blecharz Breakdown of academic impact, for papers by Breanna Wallace Breakdown of academic impact, for papers by Ming Huang Breakdown of academic impact, for papers by Fernando Neria Breakdown of academic impact, for papers by Lingwei Kong Breakdown of academic impact, for papers by Marine Poittevin Breakdown of academic impact, for papers by Olivia Singh Breakdown of academic impact, for papers by Lianhua Zhao
Rankless by CCL
2026